CPSI and PipelineRx Bringing Telepharmacy Services to Community Hospitals
November 17, 2016
CPSI Adds Remote Pharmacy Services to Aid Small and Rural
Hospitals with Efficiency, Quality of Care
MOBILE, Ala.--(BUSINESS WIRE)--
CPSI (NASDAQ: CPSI), a leading provider of healthcare information
solutions, today announced that the Company has teamed with PipelineRx
to offer a cutting edge telepharmacy solution designed to help small and
rural community hospitals provide first-class care. The remote pharmacy
solution through PipelineRx will be sold by TruBridge, the member of the
CPSI family that provides business, IT and management consulting and
services.
“Adding remote, real-time medication order review and verification
services to our broad set of healthcare IT solutions for community
hospitals will help them overcome a very common resource challenge,”
said Boyd Douglas, president and chief executive officer of CPSI.
San Francisco-based PipelineRx maintains a team of more than 100
experienced clinical pharmacists that uses best practices in medication
management and verification to ensure accuracy, quality, safety, and
optimal turnaround time 24/7. PipelineRx serves nearly 300 acute and
specialty hospitals across the country.
“Our cost-effective model helps hospitals improve care and medication
safety for their patient populations,” said Brian Roberts, chief
executive officer of PipelineRx. “Our technology-enabled telepharmacy
services will bring measurable clinical and fiscal value to acute and
post-acute customers in the CPSI family of companies, and we are pleased
to be teaming up on this collaborative, cloud-based solution.”
Douglas added, “We see this partnership as a great match for our company
and for our customers. Addressing this very real need for additional
resources fills our customers’ pharmaceutical coverage gap with
professional, secure and premium-quality pharmacy services. We have
begun the first phase of integration, which will bring the functionality
and workflow associated with telepharmacy into our Evident and Centriq
Electronic Health Records (EHR) solutions for the hospital setting. Once
we complete this phase, we intend to integrate telepharmacy into our
American HealthTech solutions for our post-acute customers.
“The PipelineRx announcement is the latest in a series of partnerships
and product enhancements by CPSI designed to help community providers
and leaders navigate the changing world of healthcare delivery,
reimbursement and management,” Douglas concluded.
About CPSI
CPSI is a leading provider of healthcare IT solutions and services for
rural and community hospitals and post-acute care facilities. Founded in
1979, CPSI is the parent of five companies – Evident, LLC, TruBridge,
LLC, Healthland Inc., American HealthTech, Inc., and Rycan Technologies,
Inc. Our combined company is focused on helping improve the health of
the communities we serve, connecting communities for a better patient
care experience, and improving the financial operations of our
customers. Evident provides comprehensive EHR solutions and services for
rural and community hospitals. TruBridge focuses exclusively on
providing business management, consulting and managed IT services to
rural and community healthcare organizations, regardless of their IT
vendor. Healthland provides integrated technology solutions and services
to small rural and critical access hospitals. American HealthTech is one
of the nation’s largest providers of financial and clinical technology
solutions and services for post-acute care facilities. Rycan provides
revenue cycle management and workflow and automation software to
hospitals, healthcare systems, and skilled nursing organizations. For
more information, visit www.cpsi.com,
www.evident.com,
www.trubridge.com,
www.healthland.com,
www.healthtech.net
or www.rycan.com.
About PipelineRx
PipelineRx is the leading independent technology-enabled telepharmacy
solutions provider serving nearly 300 acute and specialty hospitals. The
Company’s pharmacy workforce solutions enable hospitals to dramatically
increase operating efficiencies while ensuring medication efficacy,
increasing patient safety, and improving clinical outcomes. PipelineRx
differentiates its unique services via its integrated, private,
cloud-based technology platform and its optimized, distributed
telepharmacist network. PipelineRx is privately held and is
headquartered in San Francisco, California.
Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of the "safe harbor" provisions of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements can be
identified generally by the use of forward-looking terminology and words
such as "expects," "anticipates," "estimates," "believes," "predicts,"
"intends," "plans," "potential," "may," "continue," "should," "will" and
words of comparable meaning. Without limiting the generality of the
preceding statement, all statements in this press release relating to
estimated and projected earnings, margins, costs, expenditures, cash
flows, growth rates, shareholder returns and future financial results
are forward-looking statements. We caution investors that any such
forward-looking statements are only predictions and are not guarantees
of future performance. Certain risks, uncertainties and other factors
may cause actual results to differ materially from those projected in
the forward-looking statements. Such factors may include: overall
business and economic conditions affecting the healthcare industry,
including the potential effects of the federal healthcare reform
legislation enacted in 2010, and implementing regulations, on the
businesses of our hospital customers; government regulation of our
products and services and the healthcare and health insurance
industries, including changes in healthcare policy affecting Medicare
and Medicaid reimbursement rates and qualifying
technological standards; changes in customer purchasing priorities,
capital expenditures and demand for information technology systems;
saturation of our target market and hospital consolidations; general
economic conditions, including changes in the financial and credit
markets that may affect the availability and cost of credit to us or our
customers; our substantial indebtedness, and our ability to incur
additional indebtedness in the future; our inability to generate
sufficient cash in order to meet our debt service obligations;
restrictions on our current and future operations because of the terms
of our senior secured credit facilities; market risks related to
interest rate changes; our ability to successfully integrate the
businesses of Healthland, American HealthTech and Rycan with our
business and the inherent risks associated with any potential future
acquisitions; competition with companies that have greater financial,
technical and marketing resources than we have; failure to develop new
or enhance current technology and products in response to market
demands; failure of our products to function properly resulting in
claims for losses; breaches of security and viruses in our systems
resulting in customer claims against us and harm to our reputation;
failure to maintain customer satisfaction through new product releases
or enhancements free of undetected errors or problems; interruptions in
our power supply and/or telecommunications capabilities, including those
caused by natural disaster; our ability to attract and retain qualified
customer service and support personnel; failure to properly manage
growth in new markets we may enter; misappropriation of our intellectual
property rights and potential intellectual property claims and
litigation against us; changes in accounting principles generally
accepted in the United States; fluctuations in
quarterly financial performance due to, among other factors, timing of
customer installations; and other risk factors described from time to
time in our public releases and reports filed with the Securities
and Exchange Commission, including, but not limited to, our most recent
Annual Report on Form 10-K. We also caution investors that the
forward-looking information described herein represents our outlook only
as of this date, and we undertake no obligation to update or revise any
forward-looking statements to reflect events or developments after the
date of this press release.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161117005175/en/
CPSI
Tracey Schroeder, 612-787-3125
Chief Marketing Officer
tracey.schroeder@cpsi.com
Source: CPSI